Fewer Investors Than Expected Jumping On Integra LifeSciences Holdings Corporation (NASDAQ:IART)
You may think that with a price-to-sales (or "P/S") ratio of 1.5x Integra LifeSciences Holdings Corporation (NASDAQ:IART) is a stock worth checking out, seeing as almost half of all the Medical Equipm
Global Oculoplastic Surgery Market Report 2024-2030, With Key Players Bausch + Lomb, Carl Zeiss Meditec, Stryker and Integra LifeSciences Focusing on New Product Launches With Advanced Services
S&P 400 Rejig: HTZ, PENN to Exit Index; Illumina Moves Down From S&P 500
KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24
KKR (KKR), CrowdStrike (CRWD), and GoDaddy (GDDY) will replace Robert Half (RHI), Comerica (CMA), and Illumina (ILMN) in the S&P 500 index from June 24, S&P Dow Jones Indices said on Friday. Illumina
$318.8 Mn Dural Adhesive Agent for Surgical Market - Global and Regional Analysis and Forecasts, 2024-2034 Featuring Prominent Players - Integra LifeSciences, Covidien, Baxter, Johnson & Johnson - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Dural Adhesive Agent for Surgical Market - A Global and Regional Analysis: Focus on Application, Type, Form, and Country-Level Analysis - Analysis and Forecast, 2024-2034
$1.5M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed mostly higher on Friday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view t
What Does Integra LifeSciences Holdings Corporation's (NASDAQ:IART) Share Price Indicate?
Integra Lifesciences(IART.US) Officer Buys US$1.5 Million in Common Stock
$Integra Lifesciences(IART.US)$ Officer ESSIG STUART purchased 52,641 shares of common stock on May 23, 2024 at an average price of $28.4945 for a total value of $1.5 million.Source: Announcement What
Integra Lifesciences Holdings Insider Bought Shares Worth $1,499,979, According to a Recent SEC Filing
Stuart Essig, Director, Executive Chairman of the Board, on May 23, 2024, executed a purchase for 52,641 shares in Integra Lifesciences Holdings (IART) for $1,499,979. Following the Form 4 filing with
Citi Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $28
Citi analyst Joanne Wuensch maintains $Integra Lifesciences(IART.US)$ with a hold rating, and adjusts the target price from $38 to $28.According to TipRanks data, the analyst has a success rate of 62.
Integra Lifesciences(IART.US) Director Buys US$995.82K in Common Stock
$Integra Lifesciences(IART.US)$ Director HILL BARBARA B purchased 36,350 shares of common stock on May 21, 2024 at an average price of $27.3952 for a total value of $995.82K.Source: Announcement What
Integra Lifesciences Holdings Insider Bought Shares Worth $995,816, According to a Recent SEC Filing
Barbara B Hill, Director, on May 21, 2024, executed a purchase for 36,350 shares in Integra Lifesciences Holdings (IART) for $995,816. Following the Form 4 filing with the SEC, Hill has control over a
Integra LifeSciences Is Maintained at Neutral by Citigroup
Integra LifeSciences Is Maintained at Neutral by Citigroup
Citi: Maintains Integra Lifesciences (IART.US) rating, adjusted from neutral to neutral, and adjusted the target price from $24.00 to $28.00.
Citi: Maintains Integra Lifesciences (IART.US) rating, adjusted from neutral to neutral, and adjusted the target price from $24.00 to $28.00.
Citigroup Maintains Neutral on Integra Lifesciences, Raises Price Target to $28
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences with a Neutral and raises the price target from $24 to $28.
Sector Update: Health Care Stocks Steady Pre-Bell Friday
Health care stocks were steady pre-bell Friday as the Health Care Select Sector SPDR Fund (XLV) was recently inactive and the iShares Biotechnology ETF (IBB) was down a slight 0.1%. Doximity (DOCS) ra
Integra LifeSciences Holdings to Repurchase $50 Million in Shares
Integra LifeSciences Holdings (IART) said on Friday it has entered into a $50 million accelerated share repurchase agreement with Morgan Stanley & Co. LLC. The company said the repurchase transactions
Integra LifeSciences: Expansion, Audits, and Share Repurchase Plan
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
PRINCETON, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will
Deciphering Integra (IART) International Revenue Trends
Have you evaluated the performance of Integra LifeSciences' (IART) international operations during the quarter that concluded in March 2024? Considering the extensive worldwide presence of this medical device maker, analyzing the patterns in international revenues is crucial for understanding its financial resilience and potential for growth.